Silvia Aldi, PhD SKAN

Silvia Aldi, PhD

Silvia Aldi, PhD SKAN

Silvia Aldi is a SME in Cell and Gene therapy/Advanced Therapy Medicinal Products (ATMPs) manufacturing.

She has more than 10 years of expertise in R&D management and coordination of translational and pre-clinical multidisciplinary research projects. Dr Aldi received her PhD in Molecular Medicine and her Master Degree, M.Sc. in cell and molecular biology from University of Siena, Italy. As Research Coordinator at Karolinska Institutet, Stockholm, Sweden, she led the development of In Vitro Medical Device (IVD) to diagnosis of autoimmune diseases, such as rheumatoid arthritis and lupus erythematosus.

As Assistant Professor at Karolinska Institutet, she coordinated International and Interdisciplinary Seventh Framework Programs (FP7, European Commission) focused on novel targets for cardiovascular diseases.

After receiving her PhD, she was a research fellow at the Weill Cornell School of Medicine in NY, USA where she led pharmacological studies for the role of immune cells in heart failure.